Financials Omeros Corporation

Equities

OMER

US6821431029

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-07-12 pm EDT 5-day change 1st Jan Change
4.27 USD +0.47% Intraday chart for Omeros Corporation +10.48% +30.58%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 762.8 880.7 402.1 141.8 205.6 247.4 - -
Enterprise Value (EV) 1 762.8 1,110 587.5 284.6 205.6 247.4 247.4 247.4
P/E ratio -8.24 x -5.93 x 2.06 x 2.97 x -1.74 x -1.77 x -2.15 x -2.62 x
Yield - - - - - - - -
Capitalization / Revenue 6.82 x 11.9 x 3.6 x - - - 38.1 x 11 x
EV / Revenue 6.82 x 11.9 x 3.6 x - - - 38.1 x 11 x
EV / EBITDA - -8,080,963 x -2,334,928 x -872,769 x - - - -
EV / FCF - - -3,655,915 x - - - - -
FCF Yield - - -0% - - - - -
Price to Book - -7.3 x 17 x 1.66 x - - - -
Nbr of stocks (in thousands) 54,137 61,652 62,542 62,730 62,865 57,944 - -
Reference price 2 14.09 14.28 6.430 2.260 3.270 4.270 4.270 4.270
Announcement Date 3/2/20 3/1/21 3/1/22 3/13/23 4/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 111.8 73.81 111.8 - - - 6.5 22.5
EBITDA - -109 -172.2 -162.4 - - - -
EBIT 1 -63.38 -110.6 -173.6 -163.4 -164.5 -170.8 -162.4 -147.2
Operating Margin -56.69% -149.84% -155.33% - - - -2,497.69% -654.44%
Earnings before Tax (EBT) 1 -84.49 -150.1 -191.5 -182 -174.9 -177.6 -170.2 -173.3
Net income 1 -84.49 -138.1 194.2 47.42 -117.8 -153.8 -143.6 -121.2
Net margin -75.57% -187.04% 173.78% - - - -2,209.23% -538.44%
EPS 2 -1.710 -2.410 3.120 0.7600 -1.880 -2.410 -1.985 -1.630
Free Cash Flow - - -110 - - - - -
FCF margin - - -98.42% - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/2/20 3/1/21 3/1/22 3/13/23 4/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 31.88 - - - - - - - - - - - -
EBITDA -42.56 - - - - - - - - - - - -
EBIT 1 -42.89 -35.05 -37.44 -50.77 -40.14 -35.71 -40.9 -48.15 -39.76 -39.03 -47.55 -42.45 -42.25
Operating Margin -134.53% - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -47.31 -33.01 -41.7 -54.79 -46.05 -39.68 -44.29 -51.66 -39.29 -43.85 -55.6 -42.5 -42.3
Net income 1 280.6 -33.01 -30.85 -17.46 128.7 -33.7 -37.29 -37.75 -9.068 -37.18 -43.3 -37.75 -36.65
Net margin 880.24% - - - - - - - - - - - -
EPS 2 4.480 -0.5300 -0.4900 -0.2800 2.050 -0.5400 -0.5900 -0.6000 -0.1500 -0.6300 -0.6950 -0.5750 -0.5400
Dividend per Share - - - - - - - - - - - - -
Announcement Date 3/1/22 5/10/22 8/9/22 11/9/22 3/13/23 5/9/23 8/9/23 11/9/23 4/1/24 5/15/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - 230 185 143 - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - -2.106 x -1.076 x -0.8791 x - - - -
Free Cash Flow - - -110 - - - - -
ROE (net income / shareholders' equity) - 120% - - - - - -
ROA (Net income/ Total Assets) - - -63.8% - - - - -
Assets 1 - - -304.4 - - - - -
Book Value Per Share - -1.960 0.3800 1.360 - - - -
Cash Flow per Share - -1.750 -1.760 -1.380 - - - -
Capex 0.33 0.28 0.28 0.11 - - - -
Capex / Sales 0.3% 0.38% 0.25% - - - - -
Announcement Date 3/2/20 3/1/21 3/1/22 3/13/23 4/1/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4.27
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. OMER Stock
  4. Financials Omeros Corporation